3 articles
This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications…
India has protested the European Union's recent trademark reforms, highlighting concerns over potential seizures of legal pharmaceutical shipments in transit. The issue has been raised at the WTO,…
The EU’s revised trademark law empowers customs to seize in-transit goods, raising serious concerns for Indian generic pharmaceutical exports. This development challenges established principles of territorial trademark enforcement…